Number of Advanced Prostate Cancer Cases Soars
By Steven Reinberg
TUESDAY, Jul 19, 2016 (HealthDay News) — New cases of modernized prostate cancer in a United States have skyrocketed 72 percent in a past decade, a discouraging new investigate shows.
The biggest boost was among group aged 55 to 69, with a 92 percent burst seen over 10 years. This arise is worrisome given these group are a ones who might advantage many from screening and early treatment, a researchers said.
“The boost could be given a illness is apropos some-more aggressive, or it could be given there is reduction screening being done, though we don’t know why,” pronounced lead researcher Dr. Edward Schaeffer. He is chair of urology during Northwestern University’s Feinberg School of Medicine in Chicago.
It’s illusive that prostate cancer might be removing some-more aggressive, Schaeffer said, though statistics also uncover that fewer group are being screened. That’s a illusive effect of a 2012 recommendation by a U.S. Preventive Services Task Force that pronounced group should not be screened for prostate-specific antigen (PSA). PSA, a protein constructed by cells of a prostate gland, is mostly towering in group with prostate cancer.
“My vital emanate with a U.S. Preventive Services Task Force recommendation was it totally released a studious from a decision-making process,” Schaeffer said. “PSA screening saves lives, period.”
The group in a investigate who were diagnosed in 2013 contra 2004 had aloft PSAs — twice as high — that implies that these group were not good screened, Schaeffer said.
However, given modernized cancer cases began augmenting before a change in a screening recommendation, researchers can’t definitively couple a boost in cases to reduced screening alone, Schaeffer said. And this investigate was not designed to infer that possibly cause caused an boost in modernized prostate cancer cases.
Men should speak with their alloy about being screened for prostate cancer, Schaeffer said. For group with an normal risk, screening should start during 50. For group during increasing risk, screening should start during 40. Screening can stop when a male has reduction than 10 years of life expectancy, he said.